MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
Pembrolizumab in First Line Metastatic Non-squamous Non-small Cell Lung Cancer Subjects
3Phase III in Spain, 2Phase II in Spain, 1Phase I in Spain